+49 711 500 989 80
deen

Antibody with engineered peptide targets bone metastasis



Antibody with engineered peptide targets bone metastasis

A moderate amount of a peptide-enhanced cancer drug goes a long way in treating breast cancers that metastasize to the bone.

Materials provided by Rice University. Original written by Mike Williams. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

3rd October 2022

Researchers discover new molecular driver of retinoblastoma

Read more
3rd October 2022

New epigenetic markers for prostate cancer discovered

Read more
1st October 2022

Disarming the body's defenders

Read more